Literature DB >> 20383623

Oxidative stress partially contributes to iron-induced α-synuclein aggregation in SK-N-SH cells.

Wenjing Li1, Hong Jiang, Ning Song, Junxia Xie.   

Abstract

Intracellular Lewy body formation is one of the hallmarks of Parkinson's disease (PD). As its main component, aggregated α-synuclein is presented in the substantia nigra, the same region iron accumulation occurs. In this study, the relationship between iron and α-synuclein aggregation was investigated. In the remaining cells, 1 mmol/l ferric and ferrous iron could induce cell loss in SK-N-SH cells and α-synulein aggregation. Pretreatment with 5 μmol/l vitamin E, a potent intracellular reactive oxygen species (ROS) scavenger could totally abolish ROS formation and cell viability reduction induced by ferric and ferrous iron treatment. However, the intracellular α-synuclein aggregation could only be partially alleviated. Due to the predicted iron responsive element (IRE) in the 5'-untranslated region of the human α-synuclein mRNA contains, we observed that α-synuclein mRNA level was up-regulated in SK-N-SH cells with iron regulatory protein (IRP) knockdown and more α-synuclein aggregations were observed in cells. The results suggest that iron-induced intracellular aggregated α-synuclein is partially dependent on oxidative stress and iron might also regulate α-synuclein aggregation through the IRE/IRP system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383623     DOI: 10.1007/s12640-010-9187-x

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  39 in total

1.  Tip60 and HDAC7 interact with the endothelin receptor a and may be involved in downstream signaling.

Authors:  H J Lee; M Chun; K V Kandror
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

2.  The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

Authors:  N Ostrerova-Golts; L Petrucelli; J Hardy; J M Lee; M Farer; B Wolozin
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

3.  Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study.

Authors:  P F Good; C W Olanow; D P Perl
Journal:  Brain Res       Date:  1992-10-16       Impact factor: 3.252

4.  Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments.

Authors:  Nelson B Cole; Diane D Murphy; Jacob Lebowitz; Luca Di Noto; Rodney L Levine; Robert L Nussbaum
Journal:  J Biol Chem       Date:  2004-12-21       Impact factor: 5.157

5.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

6.  Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes.

Authors:  Yong Peng; Chengshan Wang; Howard H Xu; You-Nian Liu; Feimeng Zhou
Journal:  J Inorg Biochem       Date:  2009-11-18       Impact factor: 4.155

7.  Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Authors:  E C Hirsch; J P Brandel; P Galle; F Javoy-Agid; Y Agid
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

8.  Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells.

Authors:  Shuzhen Zhang; Jun Wang; Ning Song; Junxia Xie; Hong Jiang
Journal:  Neurobiol Aging       Date:  2008-01-08       Impact factor: 4.673

9.  Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers.

Authors:  Marcus Kostka; Tobias Högen; Karin M Danzer; Johannes Levin; Matthias Habeck; Andreas Wirth; Richard Wagner; Charles G Glabe; Sabine Finger; Udo Heinzelmann; Patrick Garidel; Wenzhen Duan; Christopher A Ross; Hans Kretzschmar; Armin Giese
Journal:  J Biol Chem       Date:  2008-02-07       Impact factor: 5.157

Review 10.  Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element.

Authors:  David Olivares; Xudong Huang; Lars Branden; Nigel H Greig; Jack T Rogers
Journal:  Int J Mol Sci       Date:  2009-03-17       Impact factor: 5.923

View more
  20 in total

1.  Superficial siderosis associated with abundant τ and α-synuclein accumulation.

Authors:  Masaki Takao; Shigeo Murayama; Youji Yoshida; Ban Mihara
Journal:  BMJ Case Rep       Date:  2011-12-01

Review 2.  α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.

Authors:  Sushil K Singh; Aloke Dutta; Gyan Modi
Journal:  Future Med Chem       Date:  2017-06-20       Impact factor: 3.808

3.  Alpha-synuclein aggregation is involved in the toxicity induced by ferric iron to SK-N-SH neuroblastoma cells.

Authors:  Qing He; Ning Song; Huamin Xu; Rong Wang; Junxia Xie; Hong Jiang
Journal:  J Neural Transm (Vienna)       Date:  2010-08-06       Impact factor: 3.575

4.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 5.  Iron and neurodegeneration: from cellular homeostasis to disease.

Authors:  Liliana Batista-Nascimento; Catarina Pimentel; Regina Andrade Menezes; Claudina Rodrigues-Pousada
Journal:  Oxid Med Cell Longev       Date:  2012-05-30       Impact factor: 6.543

6.  Zn²⁺ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation.

Authors:  Taiji Tsunemi; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2013-12-13       Impact factor: 5.121

Review 7.  Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.

Authors:  Yi Wang; Tian Liu
Journal:  Magn Reson Med       Date:  2014-07-17       Impact factor: 4.668

8.  Magnetic resonance imaging (MRI) to study striatal iron accumulation in a rat model of Parkinson's disease.

Authors:  Ana Virel; Erik Faergemann; Greger Orädd; Ingrid Strömberg
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

9.  A delicate balance: Iron metabolism and diseases of the brain.

Authors:  Dominic Hare; Scott Ayton; Ashley Bush; Peng Lei
Journal:  Front Aging Neurosci       Date:  2013-07-18       Impact factor: 5.750

Review 10.  Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.

Authors:  Scott Ayton; Peng Lei
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.